Video Shorts

1:00
From Bipolar Patient to TMS Researcher
2 months ago
by
Owen Muir, MD, DFAACAP, FCTMSS

0:28
Angel Investing: How Dermatologists Can Get Involved
2 months ago
by
Manju Dawkins, MD

1:03
Accelerated TMS for Rapid Relief of Suicidal Ideation
2 months ago
by
Owen Muir, MD, DFAACAP, FCTMSS

1:17
Why SWIFT TMS May Beat Inpatient Care for Suicidal Ideation
3 months ago
by
Owen Muir, MD, DFAACAP, FCTMSS

0:39
Healthcare Leadership: What to Know
3 months ago
by
Kristina Duffin, MD

1:27
Food Allergy Resolution: New Peanut Trajectory Data May Guide Risk Stratification
3 months ago
by
Mahboobeh Mahdavinia, MD, FAAAAI, PhD

1:06
The Future of Personalized Skin Care
3 months ago
by
Peter Lio, MD

0:43
The Urgent Need for Early IgA Nephropathy Detection
3 months ago
by
Samir Parikh, MD

0:48
Aficamten Clinical Results: 53% of Patients See Multi-Domain Improvement
3 months ago
by
Ahmad Masri, MD, MS

1:17
TMS Efficiency: How Treatment Room Time to Remission Has Dropped
3 months ago
by
Jonathan Downar, MD, PhD

0:45
Why Psoriasis is Often Misdiagnosed in Skin of Color
3 months ago
by
Jennifer Soung, MD(+1 more)

1:14
Scaling TMS: Can the World Reach 1 Billion Remissions?
3 months ago
by
Jonathan Downar, MD, PhD

0:43
Understanding the Patient Profile in VISIONARY Clinical Trial
3 months ago
by
Dana Rizk, MD

0:58
Upadacitinib: Why New Phase 3 Data is Significant
3 months ago
by
Charles Lynde, MD

1:11
A New Era for Insulin? Ultra-Rapid U500 Breakthrough
3 months ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+1 more)

1:12
Not Every Patient With Bronchiectasis Responds the Same to Brensocatib
3 months ago
by
Mark Metersky, MD, FCCP

0:53
Upadacitinib: Clinical Trial Results for Alopecia Areata
3 months ago
by
Melinda Gooderham, MD

0:51
50% of Your Alerts are False Positives: Here's Why
3 months ago
by
Manish Wadhwa, MD

0:43
VISIONARY Trial: Sibeprenlimab Nearly Flattens eGFR Decline in IgA Nephropathy at 2 Years, With Dana Rizk, MD
3 months ago
by
Dana Rizk, MD(+2 more)

1:13
Microneedle Peanut Allergy Patch: What's Next
3 months ago
by
Brian P. Vickery, MD

0:48
Hair Regrowth: New Data on Upadacitinib for Severe Alopecia Areata
3 months ago
by
Melinda Gooderham, MD

1:18
A 3-Minute Skin Stamp for Peanut Allergy?
3 months ago
by
Brian P. Vickery, MD

0:55
When You're Ready to Lead in Medicine
3 months ago
by
Tiffany Mayo, MD, FAAD(+1 more)

1:06
Why Mentorship is the Secret to Career Success
3 months ago
by
Jessica Mercer, MD(+1 more)

0:42
1 Year of Brensocatib: Evolving Bronchiectasis Care
3 months ago
by
Ashwin Basavaraj, MD, FCCP, ATSF

0:38
VISIONARY Trial: Sibeprenlimab Stabilizes eGFR Decline at 2 Years in IgA Nephropathy
3 months ago
by
Dana Rizk, MD(+2 more)

0:47
Why Is Access to Esketamine Clinics So Uneven?
3 months ago
by
Samuel Wilkinson, MD

1:07
Understanding U700 Insulin Dosing
3 months ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+1 more)

1:14
TMS, ECT, or VNS: Who's a Candidate for Neuromodulation?
3 months ago
by
Michael E. Thase, MD

1:08
How to Titrate Once-Weekly Insulin
3 months ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+1 more)
Advertisement
Advertisement
Trending on HCPLive
1
Upadacitinib Response Within Days in Crohn’s Disease, With Raja Atreya, MD
2
Early Dupilumab in Pediatric EoE Tied to Lower Incident Asthma
3
Stepwise Chronic Spontaneous Urticaria Management, With Timothy Craig, DO
4
Ultra-Processed Food Intake Increases Risk of HF in All Phenotypes
5
